Opioid sparing multimodal analgesia treats pain after head and neck microvascular reconstruction
The Laryngoscope Dec 08, 2019
Lee TS, et al. - In this single-institution retrospective cohort study, researchers contrasted pain control (opioid consumption and postsurgical pain scores) in head and neck (H&N) free flap reconstruction individuals who undergo traditional means of postoperative analgesia including use of opioids vs a novel protocol that involves ketamine and gabapentin. The sample consisted of 86 patients who had H&N free flap reconstruction from 2015 to 2018. Forty-three patients were treated with opioids only in the control cohort, and there were 43 patients in the treatment group. The data presented in this work showed a statistically significant reduction in opioid consumption in each of the first 5 postoperative days ranging from 80% to 83% in the treatment group. Findings suggested that ketamine and gabapentin are safe and effective analgesics in H&N free flap surgery, which in the acute postoperative setting significantly curb opioid use and can improve pain control.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries